Filter
1493
Text search:
regimens
Featured
189
362
Language
Document type
846
272
210
62
40
28
19
7
4
3
1
Countries / Regions
81
55
52
38
36
30
28
27
27
24
23
22
21
20
15
14
13
13
13
12
12
11
11
10
10
9
9
8
8
8
8
8
6
5
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
514
231
71
69
31
18
13
Toolboxes
307
253
77
51
42
41
41
31
27
21
21
17
12
12
8
7
5
5
5
4
3
2
2
2
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Accessed November 2017
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Framework for implementation.
The END TB Strategy.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Good practice guide
Supporting community action on HIV, health and rights to end AIDS
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-
...
Policy and Manual
Accessed November 2017
Accessed November 2017